ArticleProtein science : a publication of the Protein Society2026
StabLyzeGraph: High-throughput screening of combinatorial mutations using graph neural networks.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- StabLyzeGraph: High-throughput screening of combinatorial mutations using graph neural networks.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Engineering protein stability is a powerful strategy across biotechnology and medicine, supporting a broad range of applications such as atomic structure determination, discovery of therapeutic molecules, biomanufacturing, diagnostic reagents, industrial biocatalysis, etc. However, achieving rapid and significant improvements has been historically challenging due to the vast mutational space and the complex interplay of sequence, structure, and function. Indeed, traditional experimental and computational methods often struggle to predict the impact of multiple mutations and effectively integrate diverse data types. To address these limitations, we developed StabLyzeGraph, a novel computational framework powered by Graph Neural Networks (GNNs) for protein mutational analysis and classification of stabilizing mutations. StabLyzeGraph represents proteins as graphs, integrating amino acid physicochemical properties, evolutionary conservation scores, and mapped three-dimensional structural information. The framework consists of a Benchmarking module to evaluate performance, and a Screening module to identify and rank impactful mutations. Benchmarking across 23 diverse datasets demonstrated strong predictive performance, highlighting the GNN's ability to leverage integrated features. Mutational analysis enables the generation and probability scoring of single- and multi-site mutants, demonstrating the model's capacity to classify beneficial combinations of mutants based on learned structural impact rather than mere mutation frequency. StabLyzeGraph also features a user-friendly Graphical User Interface and demonstrates reasonable computational efficiency and scalability for exploring mutational landscapes. This tool provides a robust and versatile approach to accelerate the efficient discovery of stabilizing mutations with tailored properties and represents a step forward in rational protein design, poised to accelerate the creation of novel biologics with enhanced performance. StabLyzeGraph is freely available on GitHub (https://github.com/cosconatilab/StabLyzeGraph) as an open-source tool.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.